Our core technology is based on engineered terminal deoxynucleotidyl transferases (TdT) to enable the production of gene and genome libraries. Our TdT enzymes are proven to quantitatively incorporate a wide variety of reversibly terminating nucleotide triphosphates of all four nucleobases.
Nuclera's technology represents fresh approaches, which will improve cost and quality very significantly.
George Church, Professor, Harvard and MIT
Our mission is simple: provide high-quality genes and proteins at your benchtopGet in touch